US drug approvals
19 approvals with a product on the US market
- Brivaracetam ANDA220832 · approved 6 Nov 2026
- Fluvoxamine Maleate ANDA220328 · approved 30 Apr 2026
- Hydrocortisone ANDA220329 · approved 25 Feb 2026
- Sertraline Hydrochloride ANDA218712 · approved 20 Jan 2026
- Prucalopride Succinate ANDA218963 · approved 24 Jun 2025
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.